Browsing: Pharma

ZoomRx’s analysis found that cancer drugs with high physician awareness at the time of release…

Italy’s Angelini Pharma has set its sights on the lucrative U.S. market, buying rare disease…

When Optimi Health launched its 2.5 million-share initial public offering (IPO) last month (PDF), the…

Following the surprise rejection in early 2026, the FDA agreed to reconsider the T-cell therapy…

Insulet has always been a strong leader in the medical technology industry when it comes…

The FDA attacked Alnylam in an untitled letter regarding Amvuttra’s consumer website, accusing the biotech…

Since its creation by the FDA nearly a year ago, the Commissioner’s National Preference Voucher…

To better deploy field resources, FDA is kicking off a new pilot program under which…

Following a series of “most-favored-nation” (MFN) pricing agreements with 17 major pharmaceutical companies, the Trump…

Danish pharmaceutical giant Novo Nordisk has received warm feedback on its start-to-2026 performance after several…